NCT00080990View on ClinicalTrials.gov

Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

April 30, 2009

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

alvocidib

Given IV

DRUG

fluorouracil

Given IV

DRUG

oxaliplatin

Given IV

DRUG

leucovorin calcium

Given IV

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00080990 - Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter